dalteparin has been researched along with piracetam in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Prasad, K | 1 |
| Drossos, D; Giannakaki, V; Papapetrou, K; Triantafyllou, T | 1 |
| Ates, O; Dogan, M; Ersoz, E; Hacioglu Kasim, FB; Karaarslan, N; Ozbek, H; Yilmaz, I | 1 |
1 review(s) available for dalteparin and piracetam
| Article | Year |
|---|---|
Post-Traumatic Bifrontoparietal Extradural Hematoma with Superior Sagittal Sinus Detachment: A Case Report and Review of the Literature.
Topics: Adult; Anticoagulants; Anticonvulsants; Brain Injuries; Drug Therapy, Combination; Hematoma, Epidural, Cranial; Heparin, Low-Molecular-Weight; Humans; Levetiracetam; Male; Mannitol; Neuroimaging; Neuroprotective Agents; Parietal Lobe; Piracetam; Superior Sagittal Sinus; Treatment Outcome | 2016 |
2 other study(ies) available for dalteparin and piracetam
| Article | Year |
|---|---|
Publication bias perpetuates use of ineffective drugs in stroke.
Topics: Fibrinolytic Agents; Humans; Nadroparin; Nootropic Agents; Piracetam; Publication Bias; Research Design; Stroke; Treatment Outcome | 2009 |
Coexistence of SARS-CoV-2 and cerebrovascular diseases: does COVID-19 positivity trigger cerebrovascular pathologies?
Topics: Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clopidogrel; COVID-19; Enoxaparin; Humans; Mannitol; Nervous System Diseases; Piracetam; Pyrazoles; Pyridones; Retrospective Studies; SARS-CoV-2 | 2022 |